Deutsche Bank raised the firm’s price target on Fresenius Medical (FMS) to EUR 50 from EUR 45 and keeps a Hold rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS:
- Fresenius Medical extends HighVolumeHDF dialysis in Mexico
- Fresenius Medical Care removed from European Conviction List at Goldman Sachs
- Fresenius Medical price target raised to EUR 60 from EUR 55 at Berenberg
- Fresenius Medical Care: Hold Rating Amid Ambitious Targets and Execution Risks
- Fresenius Medical Care Launches EUR 1 Billion Share Buyback Program